Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma Clinical Trial
Official title:
Role of Local Therapy for Patients With Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma After Radical Treatment: a Prospective, Randomized Phase II Clinical Study
The aim of the study is to determine if intervening with combined local therapy and chemotherapy prior to chemotherapy alone in patients with oligorecurrent and oligometastatic esophageal squamous cell carcinoma led to significant improvements in progression-free survival (PFS).
n/a